BioWorld

May 24, 2006

View Archived Issues

Pharmacopeia Rises On Deal With Cephalon: $15M Up Front

Shares of Pharmacopeia Drug Discovery Inc. jumped 26.3 percent after the company signed a drug discovery deal with Cephalon Inc. that includes a $15 million up-front fee and the potential for double-digit royalties. (BioWorld Today) Read More

Avanir Buys Alamo, Gains CNS Product, Sales Force

Read More

New River Starts Phase III Study For NRP104 Against Adult ADHD

Read More

BioWorld Releases First Report On Top 25 Biotechnology Drugs

Read More

Hold On Avastin Study Lifted After 60-Day Review By DSMB

Read More

Clinic Roundup

Read More

Other News To Note

Read More

Appointments And Advancements

Read More